Castle Biosciences (CSTL) Gains from Investment Securities (2018 - 2026)
Castle Biosciences (CSTL) posted Gains from Investment Securities of $24000.0 for Q1 2026, up 100.58% sequentially from -$4.2 million in Q4 2025, and down 99.05% YoY from $2.5 million in Q1 2025.
Castle Biosciences (CSTL) Gains from Investment Securities (2018 - 2026) Analysis & Trends
Castle Biosciences (CSTL) has 9 years of Gains from Investment Securities data on file, last reported at $24000.0 in Q1 2026.
- Quarterly Gains from Investment Securities fell 99.05% year-over-year to $24000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 121.96% YoY) and the FY2025 annual result came in at $119000.0, down 98.64% from the prior year.
- Gains from Investment Securities grew to $24000.0 in Q1 2026 per CSTL's latest filing, from -$4.2 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $9.0 million in Q4 2024, with the low at -$20.4 million in Q2 2022.
- Average Gains from Investment Securities over 5 years is -$1.1 million, with a median of -$151000.0 recorded in 2022.
- Year-over-year, Gains from Investment Securities slumped 26500.0% in 2022 and jumped 1735.29% in 2025.
- Castle Biosciences' Gains from Investment Securities stood at -$4.2 million in 2022, then jumped by 98.34% to -$70000.0 in 2023, then soared by 12914.29% to $9.0 million in 2024, then sank by 146.49% to -$4.2 million in 2025, then jumped by 100.58% to $24000.0 in 2026.
- Business Quant data shows CSTL's Gains from Investment Securities at $24000.0 in Q1 2026, -$4.2 million in Q4 2025, and $4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Castle Biosciences | 738.56 Mn | 476.84 Mn | 63.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,000.00 |
| Mar 31, 2026 | 24,000.00 |
| Dec 31, 2025 | -4.17 Mn |
| Dec 31, 2025 | -4.17 Mn |
| Sep 30, 2025 | 4.17 Mn |
| Sep 30, 2025 | 4.17 Mn |
| Jun 30, 2025 | -2.40 Mn |
| Jun 30, 2025 | -2.40 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 8.97 Mn |
| Dec 31, 2024 | 8.97 Mn |
| Sep 30, 2024 | -255,000.00 |
| Sep 30, 2024 | -255,000.00 |
| Jun 30, 2024 | -427,000.00 |
| Jun 30, 2024 | -427,000.00 |
| Mar 31, 2024 | 474,000.00 |
| Mar 31, 2024 | 474,000.00 |
| Sep 30, 2023 | -70,000.00 |
| Sep 30, 2023 | -70,000.00 |